Upper gastrointestinal malignancies in the elderly.

Area of Science:

• Oncology
• Geriatric Medicine

Background:

• Upper gastrointestinal cancers predominantly affect older adults, presenting complex treatment challenges.
• Curative surgical options for these cancers carry high mortality risks in the elderly and offer limited long-term survival.
• Current chemotherapy regimens are often unsatisfactory for this patient population.

Purpose of the Study:

• To review the current treatment landscape for upper gastrointestinal cancers in the elderly.
• To explore investigational trends and palliative care options for improving outcomes in older patients.
• To highlight future therapeutic possibilities for cancer treatment in all age groups, with a focus on the elderly.

Main Methods:

• Review of current literature on upper gastrointestinal cancers in the elderly.
• Analysis of treatment modalities including surgery, chemotherapy, radiation, and palliative interventions.
• Discussion of emerging therapies such as immunotherapy and hyperthermia.

Main Results:

• Surgical resection, while offering a chance for cure, has high mortality and low long-term survival rates in elderly patients.
• Chemotherapy is currently unsatisfactory, and investigational trends favor multimodal approaches, particularly for esophageal cancer.
• Palliative options like laser therapy, nutritional support, and surgical bypass can significantly ease symptoms and prolong independence.

Conclusions:

• Treatment of upper gastrointestinal cancers in the elderly requires careful consideration of high surgical risks and limited chemotherapy efficacy.
• Multimodal therapy combinations and enhanced palliative care strategies are crucial for improving survival and quality of life.
• Emerging treatments hold promise for better cancer management in elderly patients.